Female Viagra: Pink Tablet Gets the Green Signal

  • SumoMe

Viagra-For-Woman (1)

Finally, the plight of women looking to boost their libido has been answered. A tiny pink drug named Flibanserin has been initiated by a US based Sprout Pharmaceuticals for the female sex desire. This drug, according to Sprout, is also the ultimate answer to a most common type of female sexual dysfunction known as the Hypoactive Sexual Desire Disorder (HSSD). This disorder is responsible for the lack of sexual desire in women which can also cause stress.

This pink pill got a reluctant nod from a Food and Drug Administration (FDA) panel, bringing the first medical treatment for HSSD.

Women’s low sexual desire has constantly been the topic of hot debate. Before Flibanserin, not even a single drug had been contrived to help them through this problem. And guess how many drugs have been invented so far for men’s erectile dysfunction? 20! So, can we squint our eyes a little and ask, “Why the gender discrimination?

A campaign called “Even The Score” in US had accused the FDA of not giving much emphasis to the female sexual health compared to that of men.

The FDA, however, had reportedly retorted by saying the reason for their hesitation to go ahead with the approval was their concern towards the side-effects of the pills. The decision of launching Flibanserin has also come with a lot of deliberation and conditions. Apparently, they can cause sleepiness, dizziness and nausea. FDA is also yet to test how this pill will react when used in combination with alcohol or birth control.

The main concern, however, is whether this new pill will be able to outweigh the risk portrayed by the FDA.  According to one of FDA’s recent documents, The FDA has recognized for a long time that there are women who have reduced sexual desire that causes distress, and who would benefit from safe and effective treatment. This condition is clearly an area of unmet medical need.”

Doctors suggest that the sexual dysfunction between men and women are different. Sexual dysfunction in women tends to increase physical and psychological issues as opposed to men.

Although, companies have been experimenting with similar medicines, FDA has been continuously rejecting them on basis of the risks involved in the consumption of such pills.

In a workshop organized by the International Society for the Study of Women’s Sexual Health showed that Flibanserin superseded the placebo in most of the trials. Barbara Gattuso of San Diego said at a FDA workshop that she was the one to initiate sex with her husband after taking the pill and was quite devastated when the trial had ended.

Although it is still a long way to go before these pink pills hit the markets, women can still do a nice little victory dance for such an invention!

Aishwarya Anand

Image Source: The Viewspaper

Share : Share on FacebookTweet about this on Twitter
Read previous post:
HOckey-League
World Hockey League: Here’s Why India Should Care

As the semifinals of the World Hockey League (WHL) are peeking from the horizon, the action packed hockey games are...

Close